Rofo 2023; 195(10): 890-895
DOI: 10.1055/a-2077-1387
Review

Medical historical notes on myoma treatment by uterine artery embolization on the occasion of its introduction 30 years ago

Article in several languages: English | deutsch
1   Gynecology, Charité Universitätsmedizin Berlin, Germany
,
2   Diagnostic and Interventional Radiology, Charité Universitätsmedizin Berlin, Germany
3   BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin Institute of Health at Charite, Berlin, Germany
,
Bernhard Gebauer
2   Diagnostic and Interventional Radiology, Charité Universitätsmedizin Berlin, Germany
,
Matthias David
1   Gynecology, Charité Universitätsmedizin Berlin, Germany
› Author Affiliations

Abstract

Background Since its development, uterine artery embolization (UAE) for the treatment of symptomatic fibroids has become an established minimally invasive alternative to surgical myoma treatment. Currently, more than 25,000 myoma patients worldwide are likely to be treated with UAE annually.

Method Thirty years ago, Jacques-Henri Ravina (b. 1930) and his Paris team first performed this therapy as a “substitute” for gynecologic surgery. We contacted him as part of the preparation of the present review. In addition, we performed a literature search with the aim of summarizing the current literature and data in addition to a historical account of the development of UAE.

Results and Conclusion On the occasion of this anniversary, we would like to recall the interdisciplinary roots and some facets of the history of the development of this relatively young myoma treatment method.

Key points

  1. UAE is an established minimally invasive alternative to surgical myoma treatment.

  2. UAE was first developed 30 years ago.

  3. UAE has continuously increased in importance in recent years.

Citation Format

  • Psilopatis I, Fleckenstein FN, Gebauer B et al. Medical historical notes on myoma treatment by uterine artery embolization on the occasion of its introduction 30 years ago. Fortschr Röntgenstr 2023; 195: 890 – 895



Publication History

Received: 24 November 2022

Accepted: 22 March 2023

Article published online:
19 July 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Rosch J, Dotter CT, Brown MJ. Selective arterial embolization. A new method for control of acute gastrointestinal bleeding. Radiology 1972; 102 (02) 303-306
  • 2 Guan YS, He Q, Wang MQ. Transcatheter arterial chemoembolization: history for more than 30 years. ISRN Gastroenterol 2012; 2012: 480650
  • 3 Speakman TJ. Internal Occlusion of a Carotid-Cavernous Fistula. J Neurosurg 1964; 21: 303-305
  • 4 Tadavarthy SM, Moller JH, Amplatz K. Polyvinyl alcohol (Ivalon) – a new embolic material. Am J Roentgenol Radium Ther Nucl Med 1975; 125 (03) 609-616
  • 5 Heaston DK, Mineau DE, Brown BJ. et al. Transcatheter arterial embolization for control of persistent massive puerperal hemorrhage after bilateral surgical hypogastric artery ligation. Am J Roentgenol 1979; 133 (01) 152-154
  • 6 Ledee N, Ville Y, Musset D. et al. Management in intractable obstetric haemorrhage: an audit study on 61 cases. Eur J Obstet Gynecol Reprod Biol 2001; 94 (02) 189-196
  • 7 Kivikoski AI, Martin C, Weyman P. et al. Angiographic arterial embolization to control hemorrhage in abdominal pregnancy: a case report. Obstet Gynecol 1988; 71 (03) 456-459
  • 8 Brault B, Marsault C, Moulin JD. et al. [Arterial embolization in the treatment of metrorrhagia of tumoral origin]. Nouv Presse Med 1976; 5 (16) 1043-1046
  • 9 Spies JS, Pelage JP. Uterine fibroids and fibroid embolization. Uterine Artery Embolization and Gynecologic Embolotherapy. Philadelphia: Lippincott Williams & Wilkins; 2005: 3-5
  • 10 Gonsalves C. Uterine artery embolization for treatment of symptomatic fibroids. Semin Intervent Radiol 2008; 25 (04) 369-377
  • 11 Ravina JH. History of embolization in uterine myoma. In: Tulandi T. Uterine Fibroids Embolization and other Treatments. Cambridge University Press; 2003: 80-82
  • 12 Ravina JH, Merland JJ, Herbreteau D. et al. [Preoperative embolization of uterine fibroma. Preliminary results (10 cases)]. Presse Med 1994; 23 (33) 1540
  • 13 Ravina JH, Herbreteau D, Ciraru-Vigneron N. et al. Arterial embolisation to treat uterine myomata. Lancet 1995; 346: 671-672
  • 14 Worthington-Kirsch R. Uterine Artery Embolization. Endovascular Today. 2004: 21-26
  • 15 Ravina JH. Embolization of Uterine Myoma. In: Reidy J, Hacking N, McLucas B.. Radiological Interventions in Obstetrics and Gynaecology. Berlin: Springer; 2014: vii-viii
  • 16 Goodwin SC, Walker WJ. Uterine artery embolization for the treatment of uterine fibroids. Curr Opin Obstet Gynecol 1998; 10 (04) 315-320
  • 17 Abulafia O, Sherer DM. Transcatheter uterine artery embolization for the management of symptomatic uterine leiomyomas. Obstet Gynecol Surv 1999; 54 (12) 745-753
  • 18 Royal College of Obstetricians and Gynaecologists, Royal College of Radiologists. Clinical recommendations on the use of uterine artery embolisation in the management of fibroids. Report of a joint working party. 2000
  • 19 Spies J, Niedzwiecki G, Goodwin S. et al. Training standards for physicians performing uterine artery embolization for leiomyomata: consensus statement developed by the Task Force on Uterine Artery Embolization and the standards division of the Society of Cardiovascular & Interventional Radiology--August 2000. J Vasc Interv Radiol 2001; 12 (01) 19-21
  • 20 Spies JB, Coyne K, Guaou Guaou N. et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002; 99 (02) 290-300
  • 21 CIRSE ’99 Annual Meeting and Postgraduate Course of the Cardiovascular and Interventional Radiological Society of Europe and joint meeting with the European Society of Cardiac Radiology (ESCR) Prague, Czech Republic September 26–30, 1999. Cardiovasc Intervent Radiol. 1999; 22: S60–S191
  • 22 Günther R, Siggelkow W, Vorwerk D. et al. Behandlung von Uterusmyomen durch perkutane Transkatheterembolisation: Ein viel versprechendes Verfahren zum Erhalt des Uterus. Deutsches Aerzteblatt 2002; 99 (26) 1828-1835
  • 23 Siggelkow W, Günther R, Neulen J. et al. Die perkutane Katheterembolisation – eine innovative Behandlungsalternative bei Uterusmyomen?. Geburtshilfe Frauenheilkunde 2002; 62 (02) 131-138
  • 24 Kröncke T, Gauruder-Burmester A, Hamm B. Transarterielle Embolisation von Uterusmyomen – Eine neue Therapieoption bei symptomatischem Uterus myomatosus. Fortschr Röntgenstr 2002; 174 (10) 1227-1235
  • 25 Jakobs TF, Helmberger TK, Reiser MF. Stand und Entwicklung der Uterusarterienembolisation in Deutschland. Der Radiologe 2003; 43: 615-655
  • 26 Richter GM, Radeleff B, Rimbach S. et al. [Uterine fibroid embolization with spheric micro-particles using flow guiding: safety, technical success and clinical results]. Fortschr Röntgenstr 2004; 176 (11) 1648-1657
  • 27 Kroncke T, David M, Matzko MF. Consensus meetings regarding uterine artery embolization and focused ultrasound in fibroid treatment: an analysis. Fortschr Röntgenstr 2017; 189 (06) 508-510
  • 28 Kroncke T, David M. Uterine Artery Embolization (UAE) for Fibroid Treatment – Results of the 7th Radiological Gynecological Expert Meeting. Geburtshilfe Frauenheilkd 2019; 79 (07) 688-692
  • 29 Chan P, Garcia-Reyes K, Cronan J. et al. Managing Postembolization Syndrome-Related Pain after Uterine Fibroid Embolization. Semin Intervent Radiol 2021; 38 (03) 382-387
  • 30 Torre A, Fauconnier A, Kahn V. et al. Fertility after uterine artery embolization for symptomatic multiple fibroids with no other infertility factors. Eur Radiol 2017; 27 (07) 2850-2859
  • 31 Das R, Champaneria R, Daniels JP. et al. Comparison of embolic agents used in uterine artery embolisation: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 2014; 37 (05) 1179-1190
  • 32 van der Kooij SM, Bipat S, Hehenkamp WJ. et al. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. Am J Obstet Gynecol 2011; 205 (04) 317.e1-18
  • 33 Spencer EB, Stratil P, Mizones H. Clinical and periprocedural pain management for uterine artery embolization. Semin Intervent Radiol 2013; 30 (04) 354-363
  • 34 Vorwerk D, Rosen T, Keller E. et al. [Evolution of inflammatory parameters after fibroid embolization]. Fortschr Röntgenstr 2003; 175 (02) 253-257
  • 35 Martins JG, Gaudenti D, Crespo F. et al. Uncommon Complication of Uterine Artery Embolization: Expulsion of Infarcted Myoma and Uterine Sepsis. Case Rep Obstet Gynecol 2016; 2016: 8695318
  • 36 Di Stasi C, Cina A, Rosella F. et al. Uterine fibroid embolization efficacy and safety: 15 years experience in an elevated turnout rate center. Radiol Med 2018; 123 (05) 385-397
  • 37 Poulsen B, Munk T, Ravn P. Long-term follow up after uterine artery embolization for symptomatic uterine leiomyomas. Acta Obstet Gynecol Scand 2011; 90 (11) 1281-1283
  • 38 Psilopatis I, Fleckenstein FN, Collettini F. et al. Short- and long-term evaluation of disease-specific symptoms and quality of life following uterine artery embolization of fibroids. Insights Imaging 2022; 13 (01) 106
  • 39 Scheurig-Muenkler C, Koesters C, Powerski MJ. et al. Clinical long-term outcome after uterine artery embolization: sustained symptom control and improvement of quality of life. J Vasc Interv Radiol 2013; 24 (06) 765-771
  • 40 Koesters C, Powerski MJ, Froeling V. et al. Uterine artery embolization in single symptomatic leiomyoma: do anatomical imaging criteria predict clinical presentation and long-term outcome?. Acta Radiol 2014; 55 (04) 441-449
  • 41 Tropeano G, Di Stasi C, Amoroso S. et al. Incidence and risk factors for clinical failure of uterine leiomyoma embolization. Obstet Gynecol 2012; 120 (02) 269-276
  • 42 Gabriel-Cox K, Jacobson GF, Armstrong MA. et al. Predictors of hysterectomy after uterine artery embolization for leiomyoma. Am J Obstet Gynecol 2007; 196 (06) 588.e1-e6
  • 43 DʼHoore T, Timmerman D, Laenen A. et al. Long-term outcome and pre-interventional predictors for late intervention after uterine fibroid embolization. Eur J Obstet Gynecol Reprod Biol 2020; 247: 149-155
  • 44 Goodwin SC, Spies JB, Worthington-Kirsch R. et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstet Gynecol 2008; 111 (01) 22-33
  • 45 Scheurig-Muenkler C, Lembcke A, Froeling V. et al. Uterine artery embolization for symptomatic fibroids: long-term changes in disease-specific symptoms and quality of life. Hum Reprod 2011; 26 (08) 2036-2042
  • 46 Lohle PN, Voogt MJ, De Vries J. et al. Long-term outcome of uterine artery embolization for symptomatic uterine leiomyomas. J Vasc Interv Radiol 2008; 19 (03) 319-326
  • 47 Silva N, Szejnfeld D, Klajner RK. et al. Improvement in parameters of quality of life and uterine volume reduction after uterine fibroid embolization. Einstein (Sao Paulo) 2020; 18: eAO5458
  • 48 Mara M, Maskova J, Fucikova Z. et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31 (01) 73-85
  • 49 Froeling V, Meckelburg K, Schreiter NF. et al. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol 2013; 82 (12) 2265-2269
  • 50 Goodwin SC, Vedantham S, McLucas B. et al. Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol 1997; 8 (04) 517-526